CARBOGEN AMCIS Announces Successful ANVISA Audit of Its Facility in China

BUBENDORF, Switzerland, March 19, 2024 (Korea Bizwire) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai. Between 6-10th November 2023, a five-day inspection was undertaken, which concluded successfully with no critical [...]